Jump to content

25H-NBOMe: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
No edit summary
Rescuing 0 sources and tagging 1 as dead.) #IABot (v2.0.1
Line 34: Line 34:
|drug_name=|alt=|caption=|type=|MedlinePlus=|legal_status=|licence_EU=|pregnancy_AU=|pregnancy_US=|licence_US=|DrugBank=}}
|drug_name=|alt=|caption=|type=|MedlinePlus=|legal_status=|licence_EU=|pregnancy_AU=|pregnancy_US=|licence_US=|DrugBank=}}


'''25H-NBOMe''' ('''NBOMe-2C-H''') is a derivative of the [[phenethylamine]] [[Psychedelic drug|hallucinogen]] [[2C-H]], which acts as a highly [[potency (pharmacology)|potent]] [[partial agonist]] for the [[human]] [[5-HT2A receptor|5-HT<sub>2A</sub>]] [[Receptor (biochemistry)|receptor]].<ref>https://bitnest.netfirms.com/external.php?id=%257DbxUaPRU%2505%255CG%252B%2527%252AFQ%2502%2518%2508U%250ATv</ref>
'''25H-NBOMe''' ('''NBOMe-2C-H''') is a derivative of the [[phenethylamine]] [[Psychedelic drug|hallucinogen]] [[2C-H]], which acts as a highly [[potency (pharmacology)|potent]] [[partial agonist]] for the [[human]] [[5-HT2A receptor|5-HT<sub>2A</sub>]] [[Receptor (biochemistry)|receptor]].<ref>https://bitnest.netfirms.com/external.php?id=%257DbxUaPRU%2505%255CG%252B%2527%252AFQ%2502%2518%2508U%250ATv{{Dead link|date=June 2020 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>


==Legality==
==Legality==

Revision as of 23:02, 4 June 2020

25H-NBOMe
Clinical data
ATC code
  • none
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
Identifiers
  • 2-(2,5-Dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC18H23NO3
Molar mass301.386 g·mol−1
3D model (JSmol)
  • COC1=CC(=C(C=C1)OC)CCNCC2=CC=CC=C2OC
  • InChI=1S/C18H23NO3/c1-20-16-8-9-18(22-3)14(12-16)10-11-19-13-15-6-4-5-7-17(15)21-2/h4-9,12,19H,10-11,13H2,1-3H3
  • Key:RMLXCDMTGWSEOU-UHFFFAOYSA-N

25H-NBOMe (NBOMe-2C-H) is a derivative of the phenethylamine hallucinogen 2C-H, which acts as a highly potent partial agonist for the human 5-HT2A receptor.[1]

Legality

Sweden

The Riksdag added 25H-NBOMe to Narcotic Drugs Punishments Act under swedish schedule I ("substances, plant materials and fungi which normally do not have medical use") as of August 1, 2013, published by Medical Products Agency (MPA) in regulation LVFS 2013:15 listed as 25H-NBOMe, and 2-(2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin.[2]

United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[3]

See also

References

  1. ^ https://bitnest.netfirms.com/external.php?id=%257DbxUaPRU%2505%255CG%252B%2527%252AFQ%2502%2518%2508U%250ATv[permanent dead link]
  2. ^ https://lakemedelsverket.se/upload/lvfs/LVFS_2013-15.pdf
  3. ^ "The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014". UK Statutory Instruments 2014 No. 1106. www.legislation.gov.uk.